As we just heard, Medicare has reached agreements with major pharmaceutical companies

to cut the cost the government pays for 10 prescription drugs used by millions of

Americans. This marks the first time the government has been able to negotiate directly with

drug makers, a result of provisions in the Inflation Reduction Act past two years ago.

Today in Maryland, President Biden called it a success, more than half a century in the making.

The first time I sponsored a bill to let Medicare negotiate the price of drugs was in 1973 as a freshman senator. I thank God

that in the last three months I'm president of the United States I was able to

finally get done what I tried to get done when I was a young senator.

The drug selected were some of the costliest and most frequently dispensed in the program,

including blood thinners,

Eliquis and Zarelto, medication used to treat heart failure like

in Tresto and Farcsiga, and the diabetes drugs Genuvia and Fiasp.

To discuss the impact and the implications of the drugs, Genuvia, and Fias.

To discuss the impact and the implications of the historic negotiations,

we're joined now by Nera Tandon,

domestic policy advisor to President Biden.

Nera, welcome back to the program.

Thanks for joining us. Thank you so much for having me. President Biden. Niro, welcome back to the program.

Thanks for joining us.

Thank you so much for having me.

So as the President said, it's a long time coming on these kinds of agreements.

So when will Americans actually start to feel the impact?

...